Biomea Fusion (BMEA) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T15:41:05.873Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:41:05.873Z.

Quote observation: 2026-10-06T15:40:22.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.29
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.4962

FMP input reference: ee881eee59918e8cff759d9372c22030baed04f147f6b571d3011c58a892a573

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

BMEA PE Ratio Metrics

PE RATIO

N/A

BMEA Competitors' PE Ratio

BMEA

Biomea Fusion, Inc.

Current

Market Cap

$93.27M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EQ

Equillium, Inc.

vs BMEA

Market Cap

$92.31M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs BMEA

Market Cap

$94.35M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMRA

Neumora Therapeutics, Inc. Common Stock

vs BMEA

Market Cap

$94.46M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ECOR

electroCore, Inc.

vs BMEA

Market Cap

$91.15M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PARK

Park Dental Partners, Inc. Common Stock

vs BMEA

Market Cap

$96.58M

PE Ratio

N/A

TTM Avg

13.33

3Y Avg

13.33

5Y Avg

13.33

PMVP

PMV Pharmaceuticals, Inc.

vs BMEA

Market Cap

$89.86M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ICCC

ImmuCell Corporation

vs BMEA

Market Cap

$89.11M

PE Ratio

116.43

TTM Avg

46.83

3Y Avg

44.28

5Y Avg

282.12

MIST

Milestone Pharmaceuticals Inc.

vs BMEA

Market Cap

$97.48M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs BMEA

Market Cap

$98.56M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Biomea Fusion, Inc. (BMEA)	$93.27M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$92.31M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$94.35M	N/A	N/A	N/A	N/A
Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›	$94.46M	N/A	N/A	N/A	N/A
electroCore, Inc. (ECOR)vs ›	$91.15M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$96.58M	N/A	13.33	13.33	13.33
PMV Pharmaceuticals, Inc. (PMVP)vs ›	$89.86M	N/A	N/A	N/A	N/A
ImmuCell Corporation (ICCC)vs ›	$89.11M	116.43	46.83	44.28	282.12
Milestone Pharmaceuticals Inc. (MIST)vs ›	$97.48M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$98.56M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$1.29

÷

Forward EPS (Est.)

$-0.78

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

BMEA PE Ratio Metrics

BMEA Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics